Search

Your search keyword '"Schenk, Johanna"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Schenk, Johanna" Remove constraint Author: "Schenk, Johanna"
111 results on '"Schenk, Johanna"'

Search Results

7. Monitoring of Women with Anti-Ro/SSA and Anti-La/SSB Antibodies in Germany—Status Quo and Intensified Monitoring Concepts.

13. Einleitung

14. Fluid Dynamics of the São Jorge Channel, Azores Plateau – First results of RV Meteor expedition M186

15. Multicenter clinical experience with non‐invasive cell‐free DNA screening for monosomy X and related X‐chromosome variants

16. Turner syndrome‐omphalocele association: Incidence, karyotype, phenotype and fetal outcome

18. The Value of Delta Middle Cerebral Artery Peak Systolic Velocity for the Prediction of Twin Anemia-Polycythemia Sequence—Analysis of a Heterogenous Cohort of Monochorionic Twins

21. The continuation of clinical trials in times of war: A need to develop ethics and situationally adaptive clinical research guidelines

22. The ethical responsibility to continue investigational treatments of research participants in situation of armed conflicts, economic sanctions or natural catastrophes

23. Is Fetal Hydrops in Turner Syndrome a Risk Factor for the Development of Maternal Mirror Syndrome?

24. Analysis of the Results of Sonographic Screening Examinations According to the Maternity Guidelines Before and After the Introduction of the Extended Basic Screening (IIb Screening) in Hesse

25. Is Fetal Hydrops in Turner Syndrome a Risk Factor for the Development of Maternal Mirror Syndrome?

26. Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

28. Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society

29. Leading clinical projects: a survey of clinical research professionals asked: What makes you a successful project leader?

31. Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society

40. The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development Teams

43. Corrigendum: Core competencies for pharmaceutical physicians and drug development scientists

45. Core competencies for pharmaceutical physicians and drug development scientists

48. Digesting the directive

49. Leading Clinical Projects.

50. Shaping IFAPP's Future.

Catalog

Books, media, physical & digital resources